Burden of human papillomavirus infections and related diseases in the extended middle east and North Africa Region

Vaccine

Volumn 31, Issue S6, 2013, Pages

  Vaccarella, Salvatore ^a   Bruni, Laia ^b   Seoud, Muhieddine ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cancer registry; Cervical cancer incidence; Extended Middle East and North Africa; HPV prevalence; HPV related cancers

Indexed keywords

AFGHANISTAN; AGE DISTRIBUTION; ALGERIA; ANUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CULTURAL ANTHROPOLOGY; EGYPT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IRAN; IRAQ; JORDAN; KUWAIT; LEBANON; LIBYAN ARAB JAMAHIRIYA; MIDDLE EAST; MOROCCO; MOUTH CANCER; NEOPLASM; OMAN; PAKISTAN; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; QATAR; QUALITY CONTROL; RELIGION; REVIEW; SAUDI ARABIA; SEXUAL BEHAVIOR; SYRIAN ARAB REPUBLIC; TUNISIA; TURKEY (REPUBLIC); UNITED ARAB EMIRATES; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS LOAD; VULVA CANCER; YEMEN; AFRICA; CLASSIFICATION; COMPLICATION; FEMALE; GENETICS; GENOTYPE; INCIDENCE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROCEDURES;

AFRICA, NORTHERN; COMMUNICABLE DISEASE CONTROL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 84890047813     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.098     Document Type: Review

References (75)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. 2010. Lyon, France, International Agency for Research on Cancer, Available from: http://globocan.iarc.fr. [last accessed April 2012].
2. Raza S.A., Franceschi S., Pallardy S., Malik F.R., Avan B.I., Zafar A., et al. Human papillomavirus infection in women with and without cervical cancer in Karachi. Pakistan. Br J Cancer 2010, 102:1657-1660.
3. Khodakarami N., Clifford G.M., Yavari P., Farzaneh F., Salehpour S., Broutet N., et al. Human papillomavirus infection in women with and without cervical cancer in Tehran. Iran. Int J Cancer 2012, 131:E156-E161.
4. Hammouda D., Clifford G.M., Pallardy S., Ayyach G., Chekiri A., Boudrich A., et al. Human papillomavirus infection in a population-based sample of women in Algiers. Algeria. Int J Cancer 2011, 128:2224-2229.
5. Seoud M. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. J Low Genit Tract Dis 2012, 16:106-120.
6. El-Kak F. Sexuality and sexual health: constructs and expressions in the Extended Middle East and North Africa. Vaccine 2013, 31S:G45-G50.
7. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publication No. 160. [IX]. 2007. Lyon, IARC.
8. Plummer M., Peto J., Franceschi S. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 2012, 130:2638-2644.
9. Murray C.J. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994, 72:429-445.
10. Soerjomataram I., Lortet-Tieulent J., Ferlay J., Forman D., Mathers C., Parkin D.M., et al. Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol 2012, 12:125.
11. De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626-1636.
12. de Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012, 13:607-615.
13. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
14. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjosé S., Franceschi S., et al. Human papillomavirus (HPV) types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131(10):2349-2359.
15. Bruni L., Diaz M., Castellsagué X., Ferrer E., Bosch F.X., de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202:1789-1799.
16. Keita N., Clifford G.M., Koulibaly M., Douno K., Kabba I., Haba M., et al. HPV infection in women with and without cervical cancer in Conakry. Guinea. Br J Cancer 2009, 101:202-208.
17. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
18. Franceschi S., Rajkumar R., Snijders P.J.F., Arslan A., Mahé C., Plummer M., et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005, 92:601-606.
19. Chaouki N., Bosch F.X., Muñoz N., Meijer C.J., El Gueddari B., El Ghazi A., et al. The viral origin of cervical cancer in Rabat. Morocco. Int J Cancer 1998, 75:546-554.
20. Dursun P., Senger S.S., Arslan H., Kuscu E., Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009, 9:191.
21. Kasap B., Yetimalar H., Keklik A., Yildiz A., Cukurova K., Soylu F. Prevalence and risk factors for human papillomavirus DNA in cervical cytology. Eur J Obstet Gynecol Reprod Biol 2011, 159:168-171.
22. Al-Awadhi R., Chehadeh W., Kapila K. Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol 2011, 83:453-460.
23. Mroueh A.M., Seoud M.A., Kaspar H.G., Zalloua P.A. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002, 23:429-432.
24. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128:927-935.
25. de Sanjosé S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048-1056.
26. Hammouda D., Muñoz N., Herrero R., Arslan A., Bouhadef A., Oublil M., et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005, 113:483-489.
27. Krennhrubec K., Mrad K., Sriha B., Ben A.F., Bottalico D.M., Ostolaza J., et al. HPV types and variants among cervical cancer tumors in three regions of Tunisia. J Med Virol 2011, 83:651-657.
28. Usubutun A., Alemany L., Kucukali T., Ayhan A., Yuce K., de Sanjosé S., et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009, 28:541-548.
29. Sancho-Garnier H., Chami Khazraji Y., Hamdi Cherif M., Mahnane A., Hsairi M., El Shalakamy A., et al. Overview of cervical cancer screening practices in the Extended Middle East and North Africa countries. Vaccine 2013, 31S:G51-G57.
30. Abdel Aziz M.T., Abdel Aziz M.Z., Atta H.M., Shaker O.G., Abdel Fattah M.M., Mohsen G.A., et al. Screening for human papillomavirus (HPV) in Egyptian women by the second-generation hybrid capture (HC II) test. Med Sci Monit 2006, 12:MT43-MT49.
31. Amrani M., Lalaoui K., El Mzibri M., Lazo P., Belabbas M.A. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 2003, 27:286-295.
32. Alhamany Z., El Mzibri M., Kharbach A., Malihy A., Abouqal R., Jaddi H., et al. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program. J Infect Dev Ctries 2010, 4:732-739.
33. Hassen E., Chaieb A., Letaief M., Khairi H., Zakhama A., Remadi S., et al. Cervical human papillomavirus infection in Tunisian women. Infection 2003, 31:143-148.
34. Hajjaj A.A., Senok A.C., Al-Mahmeed A.E., Issa A.A., Arzese A.R., Botta G.A. Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J 2006, 27:487-491.
35. Safaei A., Khanlari M., Momtahen M., Monabati A., Robati M., Amooei S., et al. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol 2010, 53:681-685.
36. Ghaffari S.R., Sabokbar T., Mollahajian H., Dastan J., Ramezanzadeh F., Ensani F., et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 2006, 7:529-532.
37. Zandi K., Eghbali S.S., Hamkar R., Ahmadi S., Ramedani E., Deilami I., et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J 2010, 7:65.
38. Zavarei M., Hamkar R., Dana V., Delforoosh M., Shojamoradi M., Gilani M. Prevalence of HPV Infection and Its Association with Cytological Abnormalities of Pap Smears in Tehran. Iran J Public Health 2012, 37:101-106.
39. Karam W.G., Bedran F., Tohme R., Moukarbel N., Abdallah I., Jurjus A., et al. Human papillomavirus testing as an adjunct to cytology evaluation in cervical specimens of selected and consecutively screened Lebanese women: A prospective clinical study. Leb Med J 2005, 53:132-138.
40. Inal M.M., Kose S., Yildirim Y., Ozdemir Y., Toz E., Ertopcu K., et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007, 17:1266-1270.
41. Eren F., Erenus M., Bas E., Ahiskali R., Yoldemir T. Prevalence of HPV infection by cytologic diagnosis and HPV DNA extraction and prevalence of the HPV genotypes detected in urban Turkish women. Int J Gynaecol Obstet 2010, 109:235-238.
42. Ozcan E.S., Taskin S., Ortac F. High-risk human papilloma virus prevalence and its relation with abnormal cervical cytology among Turkish women. J Obstet Gynaecol 2011, 31:656-658.
43. Ozturk S., Kaleli I., Kaleli B., Bir F. Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay. Mikrobiyol Bul 2004, 38:223-232.
44. Bayram A., Erkilic S., Balat O., Eksi F., Ugur M.G., Ozturk E., et al. Prevalence and genotype distribution of human papillomavirus in non-neoplastic cervical tissue lesion: cervical erosion. J Med Virol 2011, 83:1997-2003.
45. Altun Z., Yarkin F., Vardar M., Uguz A. The Prevalence of Human Papilloma Virus Infection Among Women who Admitted to Çukurova University Faculty of Medicine Hospital. Turkiye Klimikleri J Med Sci 2011, 31:307-314.
46. Abd El-Azim S., Lotfy M., Omr A. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate. Egypt. Clin Lab 2011, 57:363-371.
47. Ahmed M.I., Salahy E.E., Fayed S.T., El-Hefnawy N.G., Khalifa A. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001, 34:491-498.
48. El Khair M.M., Ennaji M.M., El kebbaj R., Mhand R.A., Attaleb M., El Mzibri M. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Med Oncol 2010, 27:861-866.
49. Missaoui N., Trabelsi A., Landolsi H., Jaidaine L., Mokni M., Korbi S., et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women. Asian Pac J Cancer Prev 2010, 11:777-780.
50. Missaoui N., Hmissa S., Trabelsi A., Tahar Y.M., Nouira A., Frappart L., et al. Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia. Ann Biol Clin (Paris) 2010, 68:297-303.
51. Missaoui N., Hmissa S., Trabelsi A., Frappart L., Mokni M., Korbi S. Cervix cancer in Tunisia: clinical and pathological study. Asian Pac J Cancer Prev 2010, 11:235-238.
52. Esmaeili M., Bonyadi M., Dastranj A., Alizadeh M., Melli M.S., Shobeiri M.J. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest 2008, 66:68-72.
53. Hamkar R., Azad T.M., Mahmoodi M., Seyedirashti S., Severini A., Nategh R. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J 2002, 8:805-811.
54. Mortazavi S., Zali M., Raoufi M., Nadji M., Kowsarian P., Nowroozi A. The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. Asian Pac J Cancer Prev 2002, 3:69-72.
55. Shahsiah R., Khademalhosseini M., Mehrdad N., Ramezani F., Nadji S.A. Human papillomavirus genotypes in Iranian patients with cervical cancer. Pathol Res Pract 2011, 207:754-757.
56. Allameh T., Moghim S., sadi-Zeidabadi M. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science. Arch Gynecol Obstet 2011, 284:1509-1513.
57. Sughayer M.A., Abdelhadi M., Abdeen G., Otay L., Dayeh T. Human papillomavirus genotypes in invasive cervical cancer in Jordan. Int J Gynaecol Obstet 2010, 108:74-75.
58. Khan S., Jaffer N.N., Khan M.N., Rai M.A., Shafiq M., Ali A., et al. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis 2007, 11:313-317.
59. Ozgul N., Cil A.P., Bozdayi G., Usubutun A., Bulbul D., Rota S., et al. Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity?. J Obstet Gynaecol Res 2008, 34:865-871.
60. El-All H.S., Refaat A., Dandash K. Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project. Infect Agent Cancer 2007, 2:12.
61. Younis N., Khattab H., Zurayk H., el-Mouelhy M., Amin M.F., Farag A.M. A community study of gynecological and related morbidities in rural Egypt. Stud Fam Plann 1993, 24:175-186.
62. Ben Aissa R., Bennour R., Ben Hamida A., Kammoun N., Mansour H., Mhamdi A., et al. Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP. Tunis Med 2002, 80:203-206.
63. Nokiani F.A., Akbari H., Rezaei M., Madani H., le Agha M.E. Cost--effectiveness of pap smear in Kermanshah, Iran. Asian Pac J Cancer Prev 2008, 9:107-110.
64. Luthra U.K., Chishti M., Dey P., Jolly S.V., Abdulla M., Das D.K., et al. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait. Acta Cytol 2002, 46:303-310.
65. Kapila K., George S.S., Al-Shaheen A., Al-Ottibi M.S., Pathan S.K., Sheikh Z.A., et al. Changing spectrum of squamous cell abnormalities observed on papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period. Med Princ Pract 2006, 15:253-259.
66. Karam W.G., Rady A., Abdallah H.H., Assaad I.C., Saliba J., Aftimos G., et al. Cytology and clinical spectrum of sexually transmitted infections in Lebanese women as revealed by Pap smear: a cross-sectional study from 2002-2006. J Biol Regul Homeost Agents 2011, 25:453-459.
67. Wasti S., Ahmed W., Jafri A., Khan B., Sohail R., Hassan S. Analysis of cervical smears in a Muslim population. Ann Saudi Med 2004, 24:189-192.
68. Rasul S., Khan K.S., Rizvi J.H., Hassan S.H., Maniar S. Cervical cancer screening program in a Muslim country: three-year experience at the Aga Khan University Medical Center, Karachi. Asia Oceania J Obstet Gynaecol 1991, 17:1-4.
69. Abdullah L.S. Pattern of abnormal Pap smears in developing countries: a report from a large referral hospital in Saudi Arabia using the revised 2001 Bethesda System. Ann Saudi Med 2007, 27:268-272.
70. Balaha M.H., Al Moghannum M.S., Al Ghowinem N., Al Omran S. Cytological pattern of cervical Papanicolaou smear in eastern region of Saudi Arabia. J Cytol 2011, 28:173-177.
71. Al-Jaroudi D., Hussain T.Z. Prevalence of abnormal cervical cytology among subfertile Saudi women. Ann Saudi Med 2010, 30:397-400.
72. Turkish Cervical Cancer And Cervical Cytology Research Group Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009, 106:206-209.
73. Karabulut A., Alan T., Ali Ekiz M., Iritas A., Kesen Z., Yahsi S. Evaluation of cervical screening results in a population at normal risk. Int J Gynaecol Obstet 2010, 110:40-42.
74. Yalti S., Gurbuz B., Bilgic R., Cakar Y., Eren S. Evaluation of cytologic screening results of the cervix. Int J Gynecol Cancer 2005, 15:292-294.
75. Ghazal-Aswad S., Gargash H., Badrinath P., Al-Sharhan M.A., Sidky I., Osman N., et al. Cervical smear abnormalities in the United Arab Emirates: a pilot study in the Arabian Gulf. Acta Cytol 2006, 50:41-47.